NASDAQ · Medical - Healthcare Information Services

Progyny, Inc. (PGNY) Stock

$27.96 +0.47% NASDAQ: PGNY Healthcare

Valuation

MetricValue
Price$27.96
Market Cap$2.19B
P/E Ratio26.09
P/B Ratio4.36
P/S Ratio1.51
EPS (TTM)$0.65
52-Week High$33.07
52-Week Low$16.10
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE15.98%
ROA10.98%
ROCE23.57%
Gross Margin24.11%
Operating Margin7.46%
Net Margin6.00%
Debt/Equity0.06
Current Ratio2.73

Annual Financials (USD)

Metric20212022202320242025
Revenue$501.0M$787.0M$1.1B$1.2B$1.3B
Operating Profit$32.0M$23.0M$62.0M$67.0M$85.0M
Net Profit$66.0M$30.0M$62.0M$54.0M$59.0M
EPS$0.66$0.30$0.62$0.57$0.65
Op Margin6.5%3.0%5.7%5.8%6.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$358.0M$543.0M$757.0M$607.0M$742.0M
Total Liabilities$106.0M$166.0M$203.0M$185.0M$226.0M
Cash$91.0M$120.0M$97.0M$162.0M$112.0M
Borrowings$9.0M$8.0M$19.0M$19.0M$28.0M

Latest News

PGNY: Lowering target price to $35.00 Argus Research · Jul 22, 2026 Progyny COO Cummings Sells 3,437 Shares for $109,000 -- Here's What That Means for Investors Motley Fool · Jul 19, 2026 1 Cash-Producing Stock with Competitive Advantages and 2 Facing Challenges StockStory · Jul 17, 2026 Progyny (PGNY) Stock May Be 50% Undervalued On Fresh Analyst Upgrades Simply Wall St. · Jul 16, 2026 Does Rising Analyst Optimism On June Trends Reframe Progyny’s (PGNY) Employer-Demand Story? Simply Wall St. · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$26.0M$80.0M$189.0M$179.0M$210.0M
Investing Cash Flow$7.0M$-47.0M$-204.0M$190.0M$-177.0M
Financing Cash Flow$-18.0M$-12.0M$-17.0M$-312.0M$-101.0M
Net Cash Flow$21.0M$29.0M$-23.0M$65.0M$-48.0M
Free Cash Flow$24.0M$77.0M$185.0M$174.0M$192.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.46
EV / EBITDA14.61
FCF Yield10.99%
Quick Ratio2.14
Interest Coverage0.00
Return 1Y36.42%
Return 3Y-21.51%
Return 5Y-44.61%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.68 -1.10% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Progyny, Inc.

Progyny, Inc. (PGNY) stock trades at $27.96 with a market capitalization of $2.19B. The stock is valued at a price-to-earnings (P/E) ratio of 26.09, price-to-book of 4.36, price-to-sales of 1.51. Over the past 52 weeks the stock has ranged between $16.10 and $33.07, and currently trades 15.5% below its 52-week high.

On profitability, Progyny, Inc. generates a return on equity (ROE) of 15.98%, above the typical market average, return on capital employed of 23.57%, an operating margin of 7.46%, a net profit margin of 6.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.79 +0.47% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides